Substituted [1,2,3]triazolo[4,5-d]pyrimidines

Details Substituted [1,2,3]triazolo[4,5-d]pyrimidines Substituted [1,2,3]triazolo[4,5-d]pyrimidines

2004-12-10

2008-03-18

Coleman, Brenda L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S230000, C544S254000

Reexamination Certificate

active

07345047

ABSTRACT:
The invention provides novel substituted cyclopentane compounds (in particular, substituted [1,2,3]triazolo[4,5-d]pyrimidines), their use as medicaments (in particular, their use as anti-thrombotic agents), compositions containing them and processes for their preparation.

REFERENCES:
patent: WO-99/05143 (1999-02-01), None
West, Anthony R., “Solid State Chemistry and its Applications,” Wiley, New York, pp. 358 and 365 (1988).
Patricia Clutton et al., “Pharmacological Control of Platelet Function,” Pharmacological Research 44(4):225-264 (2001).
Storey et al., “Open Multicentre Study of the P2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes,” Thromb. Haemost., Medline Abstract PMID 11307804 85(3):401-407 (2001).

Affiliated with

Also associated with

Rating

Substituted [1,2,3]triazolo[4,5-d]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted [1,2,3]triazolo[4,5-d]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted [1,2,3]triazolo[4,5-d]pyrimidines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3969361